Shares
Value
Common
Stocks
–
73.1%
Communication
Services
–
4.6%
Telesat
Corp.*
............................................................
365,781
$
4,817,336
Health
Care
–
68.5%
Abeona
Therapeutics,
Inc.*
..................................................
408,584
2,582,251
Achieve
Life
Sciences,
Inc.*
.................................................
217,845
1,032,585
Akero
Therapeutics,
Inc.*
...................................................
228,454
6,554,345
Applied
Therapeutics,
Inc.*
..................................................
2,817,505
23,948,792
Ardelyx,
Inc.*
.............................................................
689,364
4,749,718
Athira
Pharma,
Inc.*
.......................................................
1,492,792
665,785
Avidity
Biosciences,
Inc.*
...................................................
125,000
5,741,250
Chinook
Therapeutics,
Inc.*
.................................................
25,000
9,750
Eiger
BioPharmaceuticals,
Inc.*
..............................................
90,000
765,000
Kura
Oncology,
Inc.*
.......................................................
80,000
1,563,200
Kymera
Therapeutics,
Inc.*
..................................................
30,515
1,444,275
MAAT
Pharma
Saca*
......................................................
2,397
19,798
Madrigal
Pharmaceuticals,
Inc.*
..............................................
23,294
4,943,453
Phathom
Pharmaceuticals,
Inc.*
..............................................
521,935
9,436,585
Syndax
Pharmaceuticals,
Inc.*
...............................................
80,000
1,540,000
TScan
Therapeutics,
Inc.*
...................................................
1,046,916
5,213,642
Verrica
Pharmaceuticals,
Inc.*
...............................................
200,000
290,000
Zevra
Therapeutics,
Inc.*
...................................................
120,000
832,800
71,333,229
Total
Common
Stocks
(Cost
$56,033,161)
..........................................
76,150,565
Principal
U.S.
Treasury
Bills
–
35.4%
U.S.
Treasury
Bill,
4.71%,
10/22/2024(a)
(Cost
$36,900,288)
......................................................
$
37,000,000
36,897,857
Shares
Limited
Partnership
–
22.6%
Energy
–
22.6%
Plains
GP
Holdings
LP,
Class
A*
(Cost
$16,999,399)
......................................................
1,272,360
23,538,660
Principal
Corporate
Bonds
–
3.3%
Communications
–
3.3%
Telesat
Canada
/
Telesat
LLC,
5.63%,
12/6/2026,
144A(b)
.........................
$
2,700,000
1,296,125
Telesat
Canada
/
Telesat
LLC,
6.50%,
10/15/2027,
144A(b)
........................
6,124,000
2,062,630
Total
Corporate
Bonds
(Cost
$4,913,407)
...........................................
3,358,755
Total
Investments
–
134.4%
(Cost
$114,846,255)
...........................................................
$
139,945,837
Liabilities
in
Excess
of
Other
Assets
–
(34.4)%
........................................
(35,782,393)
Net
Assets
–
100.0%
............................................................
$
104,163,444
*
Non
Income
Producing
(a)
Represents
a
zero
coupon
bond.
Rate
shown
reflects
the
effective
yield.
(b)
Security
was
purchased
(sold)
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
not
be
resold
(repurchased)
subject
to
that
rule
except
to
qualified
institutional
buyers.
Unless
otherwise
noted,
Rule
144A
securities
are
deemed
to
be
liquid.
Total
fair
value
of
Rule
144A
securities
amounts
to
$3,358,755,
which
represents
3.3%
of
net
assets
as
of
September
30,
2024.
